U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
EBLASAKIMAB
INN  
Official Name English
Eblasakimab [WHO-DD]
Preferred Name English
IMMUNOGLOBULIN G4 (226-PROLINE), ANTI-(HUMAN INTERLEUKIN 13 RECEPTOR IL13RA1) (HUMAN MONOCLONAL ASLAN004 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ASLAN004 .KAPPA.-CHAIN, DIMER
Common Name English
eblasakimab [INN]
Common Name English
Code System Code Type Description
CAS
2445460-16-0
Created by admin on Wed Apr 02 07:39:31 GMT 2025 , Edited by admin on Wed Apr 02 07:39:31 GMT 2025
PRIMARY
SMS_ID
300000039126
Created by admin on Wed Apr 02 07:39:31 GMT 2025 , Edited by admin on Wed Apr 02 07:39:31 GMT 2025
PRIMARY
NCI_THESAURUS
C184861
Created by admin on Wed Apr 02 07:39:31 GMT 2025 , Edited by admin on Wed Apr 02 07:39:31 GMT 2025
PRIMARY
INN
11881
Created by admin on Wed Apr 02 07:39:31 GMT 2025 , Edited by admin on Wed Apr 02 07:39:31 GMT 2025
PRIMARY
FDA UNII
O5BD04085Y
Created by admin on Wed Apr 02 07:39:31 GMT 2025 , Edited by admin on Wed Apr 02 07:39:31 GMT 2025
PRIMARY
ACTIVE MOIETY
EBLASAKIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966